Re: 794 - Thanks for the info.
I guess the question is - is re-infection atypical? Or not?
Was the woman from Osaka completely treated and “cured” (my word).
What was the sensitivity of the test used that was used to problem her “cured”.
Just too much information not known. I’m not comfortable calling reinfection “common” (again my word) to COVID-19 when it could be atypical.
I sent you a couple of links as well...